Orchestra BioMed Holdings, Inc.

OBIO Nasdaq CIK: 0001814114

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 150 UNION SQUARE DRIVE, NEW HOPE, PA, 18938
Mailing Address 150 UNION SQUARE DRIVE, NEW HOPE, PA, 18938
Phone 646-343-9298
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
8-K Current report of material events February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC

Material Events

8-K Acquisition January 12, 2026
High Impact
  • Orchestra BioMed is set to receive up to $21 million from the Vivasure acquisition.
  • A significant cash injection of $11 million is expected in 2026, with $5 million upfront and $6 million as a first milestone payment.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.